| Zebrafish screen identifies novel compound with selective toxicity against leukemia S Ridges, WL Heaton, D Joshi, H Choi, A Eiring, L Batchelor, P Choudhry, ... Blood, The Journal of the American Society of Hematology 119 (24), 5621-5631, 2012 | 168 | 2012 |
| High-throughput method for automated colony and cell counting by digital image analysis based on edge detection P Choudhry PloS one 11 (2), e0148469, 2016 | 136 | 2016 |
| Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies ND Trinklein, D Pham, U Schellenberger, B Buelow, A Boudreau, ... mAbs, 2019 | 82 | 2019 |
| DiGeorge syndrome gene tbx1 functions through wnt11r to regulate heart looping and differentiation P Choudhry, NS Trede PLoS One 8 (3), e58145, 2013 | 49 | 2013 |
| Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma HH Huang, ID Ferguson, AM Thornton, P Bastola, C Lam, YHT Lin, ... Nature communications 11 (1), 1931, 2020 | 44 | 2020 |
| The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance ID Ferguson, B Patiño-Escobar, ST Tuomivaara, YHT Lin, MA Nix, ... Nature communications 13 (1), 4121, 2022 | 38 | 2022 |
| CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma P Ramkumar, AB Abarientos, R Tian, M Seyler, JT Leong, M Chen, ... Blood advances 4 (13), 2899-2911, 2020 | 38 | 2020 |
| Recurrent abortions in Asian Indians: no role of factor V Leiden Hong Kong/Cambridge mutation and MTHFR polymorphism A Biswas, P Choudhry, A Mittal, A Meena, R Ranjan, VP Choudhry, ... Clinical and Applied Thrombosis/Hemostasis 14 (1), 102-104, 2008 | 38 | 2008 |
| DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma P Choudhry, MC Mariano, H Geng, TG Martin III, JL Wolf, SW Wong, ... Leukemia 34 (3), 938-941, 2020 | 26 | 2020 |
| Alcama mediates Edn1 signaling during zebrafish cartilage morphogenesis P Choudhry, D Joshi, B Funke, N Trede Developmental biology 349 (2), 483-493, 2011 | 22 | 2011 |
| Seeking convergence and cure with new myeloma therapies P Choudhry, D Galligan, AP Wiita Trends in cancer 4 (8), 567-582, 2018 | 12 | 2018 |
| T Cell engagement without cytokine storm: a novel Bcma x CD3 antibody killing myeloma cells with minimal cytokine secretion B Buelow, D Pham, P Choudhry, K Dang, P Pratap, S Clarke, K Harris, ... Blood 130, 501, 2017 | 10 | 2017 |
| Defining the cell surface proteomic landscape of multiple myeloma reveals immunotherapeutic strategies and biomarkers of drug resistance ID Ferguson, BP Escobar, ST Tuomivaara, YHT Lin, MA Nix, KK Leung, ... BioRxiv, 2021.01. 17.427038, 2021 | 6 | 2021 |
| Mapping the interaction site of Rpb4 and Rpb7 subunits of RNA polymerase II in Saccharomyces cerevisiae A Sareen, P Choudhry, S Mehta, N Sharma Biochemical and biophysical research communications 332 (3), 763-770, 2005 | 5 | 2005 |
| P1189: Initial safety run-in results of the phase iii polargo trial: Polatuzumab vedotin plus rituximab, gemcitabine, and oxaliplatin in patients with relapsed/refractory … A McMillan, C Haioun, JM Sancho, A Viardot, AR Izquierdo, EMD Martin, ... HemaSphere 6, 1075-1076, 2022 | 3 | 2022 |
| Functional glycoproteomics by integrated network assembly and partitioning ME Griffin, JW Thompson, Y Xiao, MJ Sweredoski, RB Aksenfeld, ... bioRxiv, 2023 | 2 | 2023 |
| Initial safety run-in results of the phase III POLARGO trial: Polatuzumab vedotin plus rituximab, gemcitabine, and oxaliplatin in patients (pts) with relapsed/refractory … MJ Matasar, C Haioun, JM Sancho, A Viardot, A Rodriguez Izquierdo, ... Journal of Clinical Oncology 40 (16_suppl), 7551-7551, 2022 | 2 | 2022 |
| Functional multi-omics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma P Choudhry, O Gugliemini, H Geng, V Sarin, L Sarah, YHT Lin, ... Blood 138, 2648, 2021 | 2 | 2021 |
| Phase II Study of Daratumumab in Combination with Azacitidine and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients Previously Treated with Daratumumab: Darazadex S Kambhampati, SW Wong, T Martin III, JL Wolf, P Choudhry, W Karlon, ... Blood 136, 27-28, 2020 | 2 | 2020 |
| CRISPR-based screens uncover determinants of immunotherapy response and potential combination therapy strategies P Ramkumar, R Tian, M Seyler, JT Leong, M Chen, P Choudhry, ... bioRxiv, 833707, 2019 | 2 | 2019 |
Anuradha MittalThermo Fisher ScientificVerified email at chori.org
